Yüklüyor......

Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families

INTRODUCTION: The impact of crisaborole ointment, a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild to moderate atopic dermatitis (AD), on quality of life (QoL) was assessed in two identically designed phase 3 studies (AD-301: NCT02118766; AD-302: NCT02118792, both at http://www...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Dermatol Ther (Heidelb)
Asıl Yazarlar: Simpson, Eric L., Paller, Amy S., Boguniewicz, Mark, Eichenfield, Lawrence F., Feldman, Steven R., Silverberg, Jonathan I., Chamlin, Sarah L., Zane, Lee T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Healthcare 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6261115/
https://ncbi.nlm.nih.gov/pubmed/30345457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-018-0263-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!